MIMS CDS footer logo
  • Home
  • Solutions
    • MIMS Integrated
    • eMIMSplus
  • Practices
    • Hospitals
    • Pharmacies
    • Clinics
    • Telemedicine
    • Become A Partner
  • Learn More
    • Editorial Process
    • Testimonials
    • FAQs
    • Contact Support
  • Blog
  • CONTACT US

St John’s Wort: Clinically Important Drug Interactions

by MIMS CDS Asia | Mar 16, 2026 | Articles

7 minutes read time St John’s Wort (Hypericum perforatum) is a herbal medicinal product commonly used for the management of mild to moderate depressive symptoms. Its widespread availability and use alongside prescribed medicines have raised clinically relevant...

Enzyme-Inducing Antiepileptic Drugs and the Risk of Vitamin D Deficiency

by MIMS CDS Asia | Feb 6, 2026 | Articles

6 minutes read time Epilepsy is a chronic neurological disorder characterised by an enduring predisposition to generate epileptic seizures. It is defined by the International League Against Epilepsy (ILAE) as [1]: at least two unprovoked seizures occurring more than...

Understanding Hypoglycaemia Risks in Diabetes from Polypharmacy Practices

by MIMS CDS Asia | Jan 6, 2026 | Articles

6 minutes read time Hypoglycaemia, a condition in which blood glucose concentration falls below 70 mg/dL (3.9 mmol/L) [1], remains a clinically important concern for patients with Type 2 diabetes (T2DM), particularly when multiple comorbidities necessitate...

From Errors to Efficiency: Why Hospitals Can’t Afford to Skip Medication Safety

by MIMS CDS Asia | Nov 26, 2025 | Articles

5 minutes read time Medication safety underpins every phase of patient treatment. Yet without modern digital infrastructure, hospitals continue to face avoidable mistakes that place patients at risk and inflate operational costs. Medication-related clinical decision...

Clinically Significant Drug Interactions with Grapefruit: What Prescribers Need to Know

by MIMS CDS Asia | Nov 10, 2025 | Articles

4 minutes read time Grapefruit is often praised for its nutritional value, but for patients on certain medications, this seemingly harmless fruit may pose an avoidable risk. Although grapefruit-drug interactions are well-documented in literature, these risks remain...
« Older Entries

Recent Posts

  • St John’s Wort: Clinically Important Drug Interactions
  • Enzyme-Inducing Antiepileptic Drugs and the Risk of Vitamin D Deficiency
  • Understanding Hypoglycaemia Risks in Diabetes from Polypharmacy Practices
  • From Errors to Efficiency: Why Hospitals Can’t Afford to Skip Medication Safety
  • Clinically Significant Drug Interactions with Grapefruit: What Prescribers Need to Know
MIMS CDS footer logo

Safer Medications, Better Care.

  • Follow
  • Follow
Navigate
Solutions
– MIMS Integrated
– eMIMSplus
Hospitals
Pharmacies
Clinics
Blog
Editorial Process
Testimonials
FAQs
Become a Partner
Contact Us
Get In Touch


Sales

cdssales@mims.com



Support

cdssupport@mims.com



Regional Headquarters

438B Alexandra Rd, Alexandra Technopark, #06-11 Singapore 119968
Copyright © 2026 MIMS CDS Asia | Privacy Policy